Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis

IMPORTANCE: Therapeutic options for patients with secondary progressive multiple sclerosis (SPMS) are limited. OBJECTIVE: To analyze disability progression in patients with SPMS treated with rituximab compared with matched control patients never treated with rituximab. DESIGN, SETTING, AND PARTICIPA...

詳細記述

保存先:
書誌詳細
出版年:JAMA Neurol
主要な著者: Naegelin, Yvonne, Naegelin, Peter, von Felten, Stefanie, Lorscheider, Johannes, Sonder, Judith, Uitdehaag, Bernard M. J., Scotti, Barbara, Zecca, Chiara, Gobbi, Claudio, Kappos, Ludwig, Derfuss, Tobias
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2019
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439730/
https://ncbi.nlm.nih.gov/pubmed/30615019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2018.4239
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料